{"database": "lobbying", "table": "lobbying_activities", "rows": [[3243690, "429f7406-46a2-4fdf-85bb-c423ab3cfb30", "Q3", "NATIONAL FAMILY PLANNING AND REPRODUCTIVE HEALTH ASSOCIATION", 27786, "NATIONAL FAMILY PLANNING AND REPRODUCTIVE HEALTH ASSOCIATION", 2024, "third_quarter", "PHA", "340B drug pricing program", "Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE", null, null, 0, 0, "2024-10-17T13:54:49-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["3243690"], "units": {}, "query_ms": 20.738575141876936, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}